|
| H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH Basic information |
Product Name: | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH | Synonyms: | PTH-LIKE ADENYLATE CYCLASE STIMULATING PROTEIN;PTH-RELATED PEPTIDE [1-40];PTH-RELATED PROTEIN (1-40), HUMAN;PTH-RELATED PROTEIN (1-40) (HUMAN, RAT);hypercalcemia of malignancy factor-40;ala-val-ser-glu-his-gln-leu-leu-his-asp-lys-gly-lys-ser-ile-gln-asp-leu-arg-arg-arg-phe-phe-leu-his-his-leu-ile-ala-glu-ile-his-thr-ala-glu-ile-arg-ala-thr-ser;Parathyroid hormone-related protein (1-40), PTH-Like Adenylate Cyclase Stimulating Protein, PTHrP (1-40), Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser;ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATS | CAS: | 120298-73-9 | MF: | C207H334N66O58 | MW: | 4675.27426 | EINECS: | | Product Categories: | peptide | Mol File: | 120298-73-9.mol | |
| H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH Chemical Properties |
| H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH Usage And Synthesis |
| H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-GLU-ILE-ARG-ALA-THR-SER-OH Preparation Products And Raw materials |
|